Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) CEO Thomas David Hull III sold 1,368 shares of the business’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $60.08, for a total value of $82,189.44. Following the completion of the sale, the chief executive officer now owns 41,129 shares in the company, valued at $2,471,030.32. This represents a 3.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Thomas David Hull III also recently made the following trade(s):
- On Thursday, December 26th, Thomas David Hull III sold 2,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $63.01, for a total transaction of $126,020.00.
Kewaunee Scientific Stock Performance
NASDAQ:KEQU opened at $55.91 on Wednesday. Kewaunee Scientific Co. has a 52-week low of $27.00 and a 52-week high of $67.20. The business’s fifty day moving average is $49.18 and its 200 day moving average is $45.17. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The firm has a market cap of $160.57 million, a price-to-earnings ratio of 8.86 and a beta of 0.72.
Wall Street Analyst Weigh In
Read Our Latest Research Report on KEQU
Institutional Investors Weigh In On Kewaunee Scientific
Hedge funds and other institutional investors have recently modified their holdings of the stock. Dimensional Fund Advisors LP grew its stake in Kewaunee Scientific by 3.6% during the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock valued at $8,378,000 after acquiring an additional 6,132 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in Kewaunee Scientific by 13.4% in the 2nd quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock valued at $4,230,000 after purchasing an additional 10,580 shares during the period. Heron Bay Capital Management purchased a new position in shares of Kewaunee Scientific during the 2nd quarter valued at $252,000. Ritholtz Wealth Management increased its holdings in shares of Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after purchasing an additional 2,156 shares during the period. Finally, De Lisle Partners LLP raised its position in shares of Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after buying an additional 11,511 shares in the last quarter. 32.69% of the stock is currently owned by institutional investors.
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles
- Five stocks we like better than Kewaunee Scientific
- ESG Stocks, What Investors Should Know
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Stock Analyst Ratings and Canadian Analyst Ratings
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- What is the Dogs of the Dow Strategy? Overview and Examples
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.